Sage Rhino Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Buy
+13,337
New +$159K 0.03% 358
2025
Q4
Sell
-12,556
Closed -$134K 331
2025
Q3
$134K Buy
+12,556
New +$123K 0.03% 284
2025
Q2
Sell
-15,149
Closed -$226K 293
2025
Q1
$226K Buy
15,149
+79
+0.5% +$1.22K 0.05% 210
2024
Q4
$225K Sell
15,070
-852
-5% -$13.9K 0.05% 213
2024
Q3
$305K Sell
15,922
-157
-1% -$3.25K 0.07% 173
2024
Q2
$333K Buy
16,079
+915
+6% +$18.2K 0.08% 156
2024
Q1
$285K Buy
15,164
+1,556
+11% +$26.7K 0.07% 168
2023
Q4
$196K Buy
+13,608
New +$185K 0.05% 209

Other funds holding OGN

Sage Rhino Capital's OGN Position: Q2 2026 in Review

Sage Rhino Capital opened a new position in Organon & Co (OGN) in Q2 2026: 13,337 shares worth $181K. The stake represents 0.03% of the portfolio and ranks #358 among its holdings. This is a return to the name: Sage Rhino Capital previously reported a position in OGN as recently as Q3 2025.

Sage Rhino Capital first reported a position in OGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $333K in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Sage Rhino Capital held 13,337 shares of Organon & Co worth $181K as of Q2 2026.
  • Organon & Co was a new Sage Rhino Capital position in Q2 2026.
  • Organon & Co made up 0.03% of Sage Rhino Capital's portfolio in Q2 2026, its #358 holding.
  • Sage Rhino Capital first reported a position in Organon & Co in Q4 2023 and has held it in 8 quarters since.
  • Sage Rhino Capital's Organon & Co position peaked at $333K in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.